ReviewAmerican journal of nuclear medicine and molecular imaging2014
Clinical oncologic applications of PET/MRI: a new horizon.
Review in American journal of nuclear medicine and molecular imaging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02334371 (MR-PET for Staging and Assessment of Operability in Ovarian Cancer - a Feasibility Study), which is not on this map. Cited by 34 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
MR-PET for Staging and Assessment of Operability in Ovarian Cancer - a Feasibility Study
Who cites it
34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 77 citations in OpenAlex.
- FDG-PET/MRI in colorectal cancer care: an updated systematic review.Abdominal radiology (New York) · 2025Pooled it
- Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma.The Cochrane database of systematic reviews · 2021Pooled it
- Y-90 PET/MR imaging optimization with a Bayesian penalized likelihood reconstruction algorithm.Physical and engineering sciences in medicine · 2024Article
- Review
- Prospective comparison of positron emission tomography (PET)/magnetic resonance and PET/computed tomography dosimetry in hepatic malignant neoplastic disease afterJournal of gastrointestinal oncology · 2024Article
- One-Channel Microsliding Luminometer for Quantifying Low-Energy Bioluminescent Lights.Methods in molecular biology (Clifton, N.J.) · 2022Article
- Compact Eight-Channel Light-Sensing System for Bioassays.Methods in molecular biology (Clifton, N.J.) · 2022Article
- Imaging modalities in pregnant cancer patients.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2021Review
- Comparison of gross target volumes based on four-dimensional CT, positron emission tomography-computed tomography, and magnetic resonance imaging in thoracic esophageal cancer.Cancer medicine · 2020Article
- Application of integrated positron emission tomography/magnetic resonance imaging in evaluating the prognostic factors of head and neck squamous cell carcinoma with positron emission tomography, diffusion-weighted imaging, dynamic contrast enhancement and combined model.Dento maxillo facial radiology · 2020Article
- PET/CT and PET/MRI in ophthalmic oncology (Review).International journal of oncology · 2020Review
- Diagnostic efficacy of PET/CT in bone tumors.Oncology letters · 2019Article
- Does Extended PET Acquisition in PET/MRI Rectal Cancer Staging Improve Results?AJR. American journal of roentgenology · 2018Article
- Quantitative performance ofEJNMMI physics · 2018Article
- Prognostic value of simultaneousEJNMMI research · 2018Article
- An update on the role of PET/CT and PET/MRI in ovarian cancer.European journal of nuclear medicine and molecular imaging · 2017Review
- An Evaluation of the Benefits of Simultaneous Acquisition on PET/MR Coregistration in Head/Neck Imaging.Journal of healthcare engineering · 2017Article
- PET/MRI of central nervous system: current status and future perspective.European radiology · 2016Review
- Preoperative Imaging for Clinical Staging Prior to Radical Cystectomy.Current urology reports · 2016Review
- Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study.European radiology · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 2 institutions in 1 country.
Funding
Abstract
Positron emission tomography/magnetic resonance imaging (PET/MRI) leverages the high soft-tissue contrast and the functional sequences of MR with the molecular information of PET in one single, hybrid imaging technology. This technology, which was recently introduced into the clinical arena in a few medical centers worldwide, provides information about tumor biology and microenvironment. Studies on indirect PET/MRI (use of positron emission tomography/computed tomography (PET/CT) images software fused with MRI images) have already generated interesting preliminary data to pave the ground for potential applications of PET/MRI. These initial data convey that PET/MRI is promising in neuro-oncology and head & neck cancer applications as well as neoplasms in the abdomen and pelvis. The pediatric and young adult oncology population requiring frequent follow-up studies as well as pregnant woman might benefit from PET/MRI due to its lower ionizing radiation dose. The indication and planning of therapeutic interventions and specifically radiation therapy in individual patients could be and to a certain extent are already facilitated by performing PET/MRI. The objective of this article is to discuss potential clinical oncology indications of PET/MRI.
Indexed as
Identifiers
24753986PMC3992213W143755005What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.